Atul Deodhar, MD

Professor of Medicine, Division of Arthritis and Rheumatic Diseases, School of Medicine
Oregon Health & Science University
Portland, OR, United States

Professor of Medicine,
Medical Director, Rheumatology Clinics

Disclosure information not submitted.

Presentation(s):

• 0378: Prevalence of Axial Spondyloarthritis (axSpA) in Patients Treated for Chronic Back Pain in Chiropractic Clinics

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time

• 0421: Efficacy and Safety of Tofacitinib in Patients with Ankylosing Spondylitis by Prior bDMARD Treatment: Analysis of a Phase 3 Trial

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time

• 0544: Bimekizumab Improves Signs and Symptoms, Including Inflammation, in Patients with Active Non-Radiographic Axial Spondyloarthritis: 24-Week Efficacy & Safety from a Phase 3, Multicenter, Randomized, Placebo Controlled Study

  Saturday, November 12, 2022
  5:00 PM – 5:10 PM Eastern Time

• 1042: Long-term Safety of Ixekizumab in Adult Patients with Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis

  Sunday, November 13, 2022
  9:15 AM – 9:20 AM Eastern Time

• 1042: Long-term Safety of Ixekizumab in Adult Patients with Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 239: Rheum for Improvement: axial SpA and PsA

  Sunday, November 13, 2022
  6:30 PM – 8:30 PM Eastern Time

• 1776: COVID-19 Cases in Patients Treated with Secukinumab: Analysis from the Global Safety Database

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• 2124: Immunological Differences Between PsA Patients Who Are Tumor Necrosis Factor Inhibitor-Naïve and Who Have Inadequate Response to Tumor Necrosis Factor Inhibitors

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time